☰

Thomas Steinkellner - Publications

Affiliations: 
2014- University of California, San Diego, La Jolla, CA 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Steinkellner T, Conrad WS, Kovacs I, Rissman RA, Lee EB, Trojanowski JQ, Freyberg Z, Roy S, Luk KC, Lee VM, Hnasko TS. Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease. Brain : a Journal of Neurology. PMID 35258081 DOI: 10.1093/brain/awab373  0.736
2021 Souter EA, Chen YC, Zell V, Lallai V, Steinkellner T, Conrad WS, Wisden W, Harris KD, Fowler CD, Hnasko TS. Disruption of VGLUT1 in cholinergic medial habenula projections increases nicotine self-administration. Eneuro. PMID 34876472 DOI: 10.1523/ENEURO.0481-21.2021  0.727
2021 Buck SA, Steinkellner T, Aslanoglou D, Villeneuve M, Bhatte SH, Childers VC, Rubin SA, De Miranda BR, O'Leary EI, Neureiter EG, Fogle KJ, Palladino MJ, Logan RW, Glausier JR, Fish KN, et al. Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age-related neurodegeneration. Aging Cell. e13365. PMID 33909313 DOI: 10.1111/acel.13365  0.73
2021 Renteria R, Cazares C, Baltz ET, Schreiner DC, Yalcinbas EA, Steinkellner T, Hnasko TS, Gremel CM. Mechanism for differential recruitment of orbitostriatal transmission during actions and outcomes following chronic alcohol exposure. Elife. 10. PMID 33729155 DOI: 10.7554/eLife.67065  0.637
2021 Steinkellner T, Madany M, Haberl MG, Zell V, Li C, Hu J, Mackey M, Ramachandra R, Adams S, Ellisman MH, Hnasko TS, Boassa D. Genetic Probe for Visualizing Glutamatergic Synapses and Vesicles by 3D Electron Microscopy. Acs Chemical Neuroscience. PMID 33522227 DOI: 10.1021/acschemneuro.0c00643  0.723
2020 Zell V, Steinkellner T, Hollon NG, Warlow SM, Souter E, Faget L, Hunker AC, Jin X, Zweifel LS, Hnasko TS. VTA Glutamate Neuron Activity Drives Positive Reinforcement Absent Dopamine Co-release. Neuron. PMID 32610039 DOI: 10.1016/J.Neuron.2020.06.011  0.686
2020 Khom S, Steinkellner T, Hnasko TS, Roberto M. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala. Science Advances. 6: eaaz1050. PMID 32206720 DOI: 10.1126/Sciadv.Aaz1050  0.608
2019 Steinkellner T, Yoo JH, Hnasko TS. Differential expression of VGLUT2 in mouse mesopontine cholinergic neurons. Eneuro. PMID 31366590 DOI: 10.1523/ENEURO.0161-19.2019  0.779
2019 Kasture AS, Bartel D, Steinkellner T, Sucic S, Hummel T, Freissmuth M. Distinct contribution of axonal and somatodendritic serotonin transporters in drosophila olfaction. Neuropharmacology. PMID 30851308 DOI: 10.1016/J.Neuropharm.2019.03.007  0.401
2018 Reisinger SN, Kong E, Molz B, Humberg T, Sideromenos S, Cicvaric A, Steinkellner T, Yang JW, Cabatic M, Monje FJ, Sitte HH, Nichols BJ, Pollak DD. Flotillin-1 interacts with the serotonin transporter and modulates chronic corticosterone response. Genes, Brain, and Behavior. e12482. PMID 29667320 DOI: 10.1111/Gbb.12482  0.38
2018 Steinkellner T, Zell V, Farino ZJ, Sonders MS, Villeneuve M, Freyberg RJ, Przedborski S, Lu W, Freyberg Z, Hnasko TS. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons. The Journal of Clinical Investigation. PMID 29337309 DOI: 10.1172/Jci95795  0.754
2015 Steinkellner T, Montgomery TR, Hofmaier T, Kudlacek O, Yang JW, Rickhag M, Jung G, Lubec G, Gether U, Freissmuth M, Sitte HH. Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8258-71. PMID 26019340 DOI: 10.1523/Jneurosci.4034-14.2015  0.386
2014 Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, et al. In vivo amphetamine action is contingent on αCaMKII. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2681-93. PMID 24871545 DOI: 10.1038/Npp.2014.124  0.397
2014 Montgomery TR, Steinkellner T, Sucic S, Koban F, Schüchner S, Ogris E, Sitte HH, Freissmuth M. Axonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 6344-51. PMID 24790205 DOI: 10.1523/Jneurosci.2991-13.2014  0.326
2013 Buchmayer F, Schicker K, Steinkellner T, Geier P, Stübiger G, Hamilton PJ, Jurik A, Stockner T, Yang JW, Montgomery T, Holy M, Hofmaier T, Kudlacek O, Matthies HJ, Ecker GF, et al. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proceedings of the National Academy of Sciences of the United States of America. 110: 11642-7. PMID 23798435 DOI: 10.1073/Pnas.1220552110  0.367
2012 Steinkellner T, Yang JW, Montgomery TR, Chen WQ, Winkler MT, Sucic S, Lubec G, Freissmuth M, Elgersma Y, Sitte HH, Kudlacek O. Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. The Journal of Biological Chemistry. 287: 29627-35. PMID 22778257 DOI: 10.1074/Jbc.M112.367219  0.394
2012 Bulling S, Schicker K, Zhang YW, Steinkellner T, Stockner T, Gruber CW, Boehm S, Freissmuth M, Rudnick G, Sitte HH, Sandtner W. The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. The Journal of Biological Chemistry. 287: 18524-34. PMID 22451652 DOI: 10.1074/Jbc.M112.343681  0.318
2012 Steinkellner T, Montgomery T, Yang J, Rickhag M, Sucic S, Elgersma Y, Kudlacek O, Freissmuth M, Gether U, Sitte HH. Calmodulin kinase II regulates amphetamine-induced reverse transport in dopamine and serotonin transporters Bmc Pharmacology and Toxicology. 13. DOI: 10.1186/2050-6511-13-S1-A56  0.403
2011 Montgomery T, Sucic S, Steinkellner T, Freissmuth M, Sitte H. Differential regulation of amphetamine-induced serotonergic and dopaminergic efflux by syntaxin 1A Bmc Pharmacology. 11: A38. DOI: 10.1186/1471-2210-11-S2-A38  0.408
2011 Buchmayer F, Schicker K, Stübiger G, Hamilton PJ, Geier P, Jurik A, Weissensteiner R, Steinkellner T, Matthies HJ, Montgomery T, Winkler M, Yang J, Holy M, Ecker GF, Galli A, et al. Amphetamine actions rely on the availability of phosphatidylinositol-4,5-bisphosphate Bmc Pharmacology. 11: A19. DOI: 10.1186/1471-2210-11-S2-A19  0.383
2010 Steinkellner T, Kudlacek O, Freissmuth M, Elgersma Y, Sitte H. Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome Bmc Pharmacology. 10. DOI: 10.1186/1471-2210-10-S1-A19  0.444
Show low-probability matches.